“The least insecure of any messaging system,” he intoned, his voice dripping with the honeyed confidence of a man who once sold flamethrowers as novelty items. One can only marvel at the sheer bravado of such a claim, though whether it will withstand the scrutiny of the digital underworld remains a tantalizing question. 🤔
Consider the ledger:
The weighted average price-$5.76-suggests no desperation, merely the steady hand of a chessmaster moving pieces across a board where pawns become queens and queens become ghosts.
Aditya Palepu, the big boss at DEX Labs (he’s basically the superhero of crypto derivatives), says this MEV nonsense keeps the serious financial folks from jumping into DeFi-probably because they don’t fancy getting sandwiched or front-run before they even place their order. Imagine trying to buy a burger, only to find someone else ordered it first and then jacked up the price! 😂
in a world where the line between hero and profiteer blurs, who watches the watchers? 🕵️♂️
According to Jurgilas, the future of finance isn’t about speculative hype (though we all love a good bubble, don’t we? 🧼💸). No, it’s about regulated scale, compliance, and trust-the holy trinity of institutional opportunity, worth trillions of space credits. 🏦💰
Trade direction: buy; position now represents 3.48% of the reported 13F assets under management. The long-term gambler watches, as the markets unfold like the slow march of time itself, witnessing new twists as old stakes are gradually raised.
Dogecoin (DOGE), the once-mighty doge of the crypto realm, now limps along with a mere 0.6% gain, as if it’s been chased by a very grumpy squirrel. Stagnating at $0.1871, it’s like a teacup that forgot how to sip. Dogecoin’s market cap, $27.4 billion, is a number so large it could buy a small island… if the island was made of paper. 🐕💸
According to a document filed with the Securities and Exchange Commission (a body whose primary purpose seems to be ensuring that paperwork remains the universe’s most enduring constant), Palisades had, during the third quarter, divested itself entirely of ADMA Biologics. This involved the sale of 398,647 shares, a number that sounds precise until you realize it’s roughly the population of a small island nation. The fund now holds precisely zero ADMA shares, a state of affairs as absolute as the heat death of the universe.
Weighted average price? A nice round $169.56 per share-now that’s a good day at the office.
Yet, let us not mistake ambition for substance. Upstart, though bold, remains a modest creature, its market cap a mere $4.5 billion-a pittance compared to the leviathan of Affirm. The stock, a ghost of its former self, lingers 88% below its peak, as if haunted by the specter of past misfortunes.
